Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms

NCT03991520 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03991520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03991520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Unknown status
Start date
June 16, 2020
Completion date
January 31, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anakinra, endometriosis, markers of inflammation